TIZANIDINTHERAPIESYSTEM

Patent europeic · EP3818982 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3818982
Numer da la dumonda
EP19746696
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
31-01-2019
Publitgà
12-05-2021
Concedì
20-12-2023
Stritgà
24-08-2024
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 31/433 (2006.01)
A61K 9/70 (2006.01)
A61K 47/10 (2017.01)
A61K 47/12 (2006.01)
A61P 25/08 (2006.01)
Prioritad
JP 2018016010 31.01.2018
JP 2018016011 31.01.2018
JP 2018016804 01.02.2018
JP 2018016805 01.02.2018
Dumonda PCT
PCT/JP2019/003453 31.01.2019
Publicaziun PCT
WO2019/151423 08.08.2019
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 30-10-2024

    Midada

    Published in Swissreg on 30.10.2024

  2. 24-08-2024

    Stritgà, taxa betg pajada

    Published in Swissreg on 24.08.2024

  3. 20-12-2023

    Concedì

    Published in Swissreg on 20.12.2023

Partidas

Possessur

MEDRx Co., Ltd.

Medrx Co., Ltd.

431-7 Nishiyama Higashikagawa-shi, Kagawa 769-2712, JP

Inventur

HAMAMOTO, Hidetoshi

Kagawa 769-2712, JP

MIWA, Yasushi

Kagawa 769-2712, JP

AKAZAWA, Naoya

Kagawa 769-2712, JP

TANIMOTO, Takahiro

Kagawa 769-2712, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.